| Literature DB >> 32219563 |
Andrea Schmedding1, Boris Wittekind2, Emilia Salzmann-Manrique3, Rolf Schloesser2, Udo Rolle4.
Abstract
PURPOSE: Neonatal surgery for abdominal wall defects is not performed in a centralized manner in Germany. The aim of this study was to investigate whether treatment for abdominal wall defects in Germany is equally effective compared to international results despite the decentralized care.Entities:
Keywords: Child; Gastroschisis; Mortality; Neonatal surgery outcome; Omphalocele
Mesh:
Year: 2020 PMID: 32219563 PMCID: PMC7165189 DOI: 10.1007/s00383-020-04647-7
Source DB: PubMed Journal: Pediatr Surg Int ISSN: 0179-0358 Impact factor: 1.827
Employment status and age under 15 years for people with health insurance
| 2011 microcensus of Germany | Employed | Jobless | Not working (e.g. children, retired) | Age less than 15 years |
|---|---|---|---|---|
| All people with health insurance | 52% | 3% | 48% | 13% |
| All people in statutory health insurance | 48% | 3% | 49% | 13% |
| AOK | 41% | 5% | 54% | 13% |
Distribution of diseases over the 5-year period
| All | Male | Female | BW < 1500 g | Non-survivor | |
|---|---|---|---|---|---|
| Gastroschisis | |||||
| 2009 | 61 | 36 | 25 | 6 | 3 |
| 2010 | 69 | 36 | 33 | 3 | 2 |
| 2011 | 63 | 28 | 34 | 5 | 3 |
| 2012 | 55 | 29 | 26 | 2 | 3 |
| 2013 | 68 | 37 | 30 | 5 | 1 |
| All | 316 | 166 | 148 | 21 | 12 |
| % | 53% | 47% | 7% | 4% | |
| Omphalocele | |||||
| 2009 | 34 | 14 | 20 | 3 | 4 |
| 2010 | 42 | 28 | 14 | 0 | 7 |
| 2011 | 42 | 24 | 17 | 5 | 8 |
| 2012 | 46 | 25 | 20 | 4 | 6 |
| 2013 | 33 | 20 | 11 | 3 | 7 |
| All | 197 | 111 | 82 | 15 | 32 |
| % | 58% | 42% | 8% | 16% | |
BW birth weight
Distribution of related associated anomalies and relation to survival
| Gastroschisis | Omphalocele | |||
|---|---|---|---|---|
| All (%) | Non-survivors (%) | All (%) | Non-survivors (%) | |
| Numbers | 316 | 12 | 198 | 32 (16) |
| Male | 166 (53) | 4 (33) | 111 (58) | 10 (31) |
| Birth weight < 1500 g | 21 (7) | 4 (33) | 15 (8) | 8 (25) |
| Intestinal problemsa | 58 (18) | 6 (50) | 13 (7) | 3 (9) |
| Atresia of small bowel | 35 (11) | 3 (25) | 6 (3) | 0 |
| Atresia of colon | 22 (7) | 2 (17) | 4 (2) | 1 (3) |
| Volvulus | 8 (3) | 2 (17) | 1 (1) | 0 |
| Abnormal vascular supply of intestine | 13 (4) | 3 (25) | 3 (2) | 2 (6) |
| Cardiac anomalies | 32 (10) | 0 | 63 (32) | 17 (53) |
| Lung hypoplasia | 1 (< 1) | 1 (8) | 9 (5) | 7 (22) |
| Diaphragmatic hernia | 0 | 0 | 4 (2) | 2 (6) |
| Anomalies of urinary tract | 17 (5) | 0 | 19 (10) | 5 (16) |
| Anomalies of spine or thorax | 0 | 0 | 3 (2) | 1 (3) |
| Trisomy 18 or 21 | 0 | 0 | 15 (8) | 13 (41) |
n.d.a. no data available, CAW closure of abdominal wall without synthetic material, IRQ interquartile range
aIn gastroschisis correspondent with complex gastroschisis
Fig. 1Gastroschisis: association with non-survival the first year of life. Forest plot shows the unadjusted odds ratio in base-10 log scale. Non-Surv non-survivors, CI confidence interval, Pp value
Fig. 2Omphalocele: association with non-survival during the first year of life. The forest plot shows the unadjusted odds ratio on a base-10 log scale. Non-Surv non-survivors, CI confidence interval, Pp value
Fig. 3Omphalocele: forest plot showing the adjusted odds ratio associated with non-survival in the first year of life on a base-10 log scale. Non-Surv non-survivors, CI confidence interval, Pp value
Fig. 4Gastroschisis. Cumulative incidence curves for hospital discharge. The curves do not reach 100% because fatalities before discharge were considered competing risks
Fig. 5Omphalocele. Cumulative incidence curves for hospital discharge. The curves do not reach 100% because fatalities before discharge were considered competing risks. It was not possible to calculate a median for omphalocele patients with lung hypoplasia, and trisomy 18 and 21 because 78% and 87% of the patients died before discharge
Comparison of our data with literature
| Gastroschisis | Omphalocele | |||
|---|---|---|---|---|
| Our data | literaturea | Our data | literaturea | |
| Male (%) | 53 | 52–54 | 58 | 51–59 |
| < 1500 g (%) | 7 | 0.1–5.6 | 8 | 6–8 |
| Cardiac (%) | 10 | 1–15 | 32 | 11–56 |
| Pulmonary (%) | < 1 | < 1–5 | 5 | 2–8 |
| Gastrointestinal (%) | 18 | 5–15 | 7 | 7–15 |
| Urologic (%) | 5 | 1–15 | 10 | 6–17 |
| Genetic (%) | 0 | 0.1–1.7 | 8 | 15–32 |
| Length of stay (median) | 39 | 25–45 | 15 | 15–23 |
| Mortality (%) | 4 | 1,4–6,5 | 16 | 16–19 |
a[24, 30, 31, 34–41]